214 related articles for article (PubMed ID: 3202901)
1. A comparative study of 1-substituted imidazole and 1,2,4-triazole antifungal compounds as inhibitors of testosterone hydroxylations catalysed by mouse hepatic microsomal cytochromes P-450.
Ballard SA; Lodola A; Tarbit MH
Biochem Pharmacol; 1988 Dec; 37(24):4643-51. PubMed ID: 3202901
[TBL] [Abstract][Full Text] [Related]
2. Hydroxylation of 5 alpha-androstane-3 beta,17 beta-diol by rat prostate microsomes: potent inhibition by imidazole-type antimycotic drugs and lack of inhibition by steroid 5 alpha-reductase inhibitors.
Gemzik B; Parkinson A
Arch Biochem Biophys; 1992 Aug; 296(2):366-73. PubMed ID: 1632630
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of antithrombitic and antimycotic N-substituted imidazoles on rat hepatic microsomal steroid and xenobiotic hydroxylases in vitro.
Murray M; Zaluzny L
Biochem Pharmacol; 1988 Feb; 37(3):415-20. PubMed ID: 3337742
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agents.
Sheets JJ; Mason JI; Wise CA; Estabrook RW
Biochem Pharmacol; 1986 Feb; 35(3):487-91. PubMed ID: 3947383
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cytochromes P450 by antifungal imidazole derivatives.
Zhang W; Ramamoorthy Y; Kilicarslan T; Nolte H; Tyndale RF; Sellers EM
Drug Metab Dispos; 2002 Mar; 30(3):314-8. PubMed ID: 11854151
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two azole antifungal drugs, ketoconazole, and fluconazole, as modifiers of rat hepatic monooxygenase activity.
Houston JB; Humphrey MJ; Matthew DE; Tarbit MH
Biochem Pharmacol; 1988 Feb; 37(3):401-8. PubMed ID: 2827686
[TBL] [Abstract][Full Text] [Related]
7. Induction potential of antifungals containing an imidazole or triazole moiety. Miconazole and ketoconazole, but not itraconazole are able to induce hepatic drug metabolizing enzymes of male rats at high doses.
Lavrijsen K; Van Houdt J; Thijs D; Meuldermans W; Heykants J
Biochem Pharmacol; 1986 Jun; 35(11):1867-78. PubMed ID: 3013201
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibition of hepatic steroid hydroxylation by tamoxifen, a series of tamoxifen analogues and related compounds.
Reidy GF; Murray M
Biochem Pharmacol; 1989 Jan; 38(1):195-9. PubMed ID: 2910300
[TBL] [Abstract][Full Text] [Related]
9. Imidazole antimycotics: selective inhibitors of steroid aromatization and progesterone hydroxylation.
Mason JI; Carr BR; Murry BA
Steroids; 1987; 50(1-3):179-89. PubMed ID: 3504059
[TBL] [Abstract][Full Text] [Related]
10. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
Murray M
Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757
[TBL] [Abstract][Full Text] [Related]
11. Spectral and kinetic studies of the interaction of imidazole anti-fungal agents with microsomal cytochromes P-450.
Rodrigues AD; Lewis DF; Ioannides C; Parke DV
Xenobiotica; 1987 Nov; 17(11):1315-27. PubMed ID: 3433801
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of ketoconazole and miconazole on cytochrome P-450-mediated oxidative metabolism of testosterone and xenobiotics in mouse hepatic microsomes--comparative study with cimetidine.
Morita K; Ono T; Shimakawa H
J Pharmacobiodyn; 1988 Feb; 11(2):106-14. PubMed ID: 3379563
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of testicular 17 alpha-hydroxylase and 17,20-lyase but not 3 beta-hydroxysteroid dehydrogenase-isomerase or 17 beta-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs.
Ayub M; Levell MJ
J Steroid Biochem; 1987 Nov; 28(5):521-31. PubMed ID: 2824931
[TBL] [Abstract][Full Text] [Related]
14. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
[TBL] [Abstract][Full Text] [Related]
15. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
Murray M; Field SL
Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies inhibitory to rat hepatic cytochromes P-450: P-450 form specificities and use as probes for cytochrome P-450-dependent steroid hydroxylations.
Waxman DJ; Lapenson DP; Park SS; Attisano C; Gelboin HV
Mol Pharmacol; 1987 Nov; 32(5):615-24. PubMed ID: 3119986
[TBL] [Abstract][Full Text] [Related]
17. Induction of the rat hepatic microsomal mixed-function oxidases by 3 imidazole-containing antifungal agents: selectivity for the cytochrome P-450IIB and P-450III families of cytochromes P-450.
Rodrigues AD; Waddell PR; Ah-Sing E; Morris BA; Wolf CR; Ioannides C
Toxicology; 1988 Aug; 50(3):283-301. PubMed ID: 3394156
[TBL] [Abstract][Full Text] [Related]
18. The xenobiotic inhibitor profile of cytochrome P4502C8.
Ong CE; Coulter S; Birkett DJ; Bhasker CR; Miners JO
Br J Clin Pharmacol; 2000 Dec; 50(6):573-80. PubMed ID: 11136296
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
20. Investigation into UDP-glucuronosyltransferase (UGT) enzyme kinetics of imidazole- and triazole-containing antifungal drugs in human liver microsomes and recombinant UGT enzymes.
Bourcier K; Hyland R; Kempshall S; Jones R; Maximilien J; Irvine N; Jones B
Drug Metab Dispos; 2010 Jun; 38(6):923-9. PubMed ID: 20304965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
